Your browser doesn't support javascript.
loading
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia.
Dreisig, Karin; Brünner, Emilie Damgaard; Marquart, Hanne V; Helt, Louise Rold; Nersting, Jacob; Frandsen, Thomas Leth; Jonsson, Olafur Gisli; Taskinen, Mervi; Vaitkeviciene, Goda; Lund, Bendik; Abrahamsson, Jonas; Lepik, Kristi; Schmiegelow, Kjeld.
Afiliación
  • Dreisig K; Pediatric Oncology research laboratory, The University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Brünner ED; Pediatric Oncology research laboratory, The University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Marquart HV; The Tissue Typing Laboratory, Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Helt LR; Pediatric Oncology research laboratory, The University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Nersting J; Pediatric Oncology research laboratory, The University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Frandsen TL; Department of Pediatrics and adolescent medicine, The University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Jonsson OG; Department of Pediatrics, University of Iceland, Reykjavík, Iceland.
  • Taskinen M; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children and Adolescents, Helsinki University Hospital, Helsinki, Finland.
  • Vaitkeviciene G; Children's Hospital, Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania.
  • Lund B; Department of Pediatrics, St. Olavs Hospital, Trondheim; Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Abrahamsson J; Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Lepik K; Tallinn Children's Hospital, Tallinn, Estonia.
  • Schmiegelow K; Pediatric Oncology research laboratory, The University Hospital Rigshospitalet, Copenhagen, Denmark.
Pediatr Hematol Oncol ; 38(3): 227-238, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33205673
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mercaptopurina / Metiltransferasas / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Child / Female / Humans / Male Idioma: En Revista: Pediatr Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mercaptopurina / Metiltransferasas / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline Límite: Child / Female / Humans / Male Idioma: En Revista: Pediatr Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca